Pharmaceutical Technology, 2019 Buyers Guide (PDF)

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-06-01-2019
Volume Supplement 2019
Issue 3

Click the title above to open the Pharmaceutical Technology 2019 Buyers Guide in an interactive PDF format.

External Link - PharmTech_2019_BuyersGuide.pdf

Download Issue PDF
Articles in this issue
Pharmaceutical Technology, 2019 Buyers Guide (PDF)
Recent Videos
Inside Experic: Revolutionizing CDMO & Clinical Packaging Services
Inside Experic: Revolutionizing CDMO & Clinical Packaging Services
Drug Digest: Patient Preference Drives Solid Dosage Trends
Drug Digest: Patient Preference Drives Solid Dosage Trends
Ask the Expert: Quality Control Units
Ask the Expert: Quality Control Units
Behind the Headlines, Episode 17
Behind the Headlines, Episode 17: Bespoke CRISPR Therapy, Executive Order Fallout, and More
Industry Outlook 2025: European Political Impacts on the Supply Chain
Industry Outlook 2025: European Political Impacts on the Supply Chain
AAPS National Biotechnology Conference 2025: High-Concentration Biologics
AAPS National Biotechnology Conference 2025: High-Concentration Biologics
Industry Outlook 2025: The Future of Technology in the Biopharma Industry
Industry Outlook 2025: The Future of Technology in the Biopharma Industry
AAPS National Biotechnology Conference 2025: AAV Vector Production
AAPS National Biotechnology Conference 2025: AAV Vector Production
Gaylord Chemical is Now gChem
Gaylord Chemical is Now gChem
BioDuro is Redefining CRDMO Partnerships With End-to-End Innovation
BioDuro is Redefining CRDMO Partnerships With End-to-End Innovation
Related Content
Site Logo

Trends in Manufacturing eBook May 2025

May 27th 2025
Article
Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Data technology background. Abstract background. Connecting dots and lines on dark background. 3D rendering. 4k. | Image Credit: © Dmitry

Emerson Unveils AI Platform for Mission-Critical Industrial Applications

Christopher Cole
May 22nd 2025
Article

Emerson’s purpose-built industrial AI solutions are meant to enhance accessibility and reliability, enabling manufacturers to maximize efficiency and performance from automation systems.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

·Mirai Bio and Thermo Fisher are partnering to integrate design, delivery, and CGMP manufacturing for nucleic acid-based therapeutics. ·The collaboration will leverage Thermo Fisher’s RNA and advanced formulations facility to support scalable development of genetic medicines. ·Mirai’s machine intelligence platform will be combined with Thermo Fisher’s technical and manufacturing expertise to streamline drug development workflows.

Mirai Bio and Thermo Fisher Partner to Advance Genetic Medicine Manufacturing

Christopher Cole
May 21st 2025
Article

Mirai Bio and Thermo Fisher partner to integrate AI-driven design with CGMP manufacturing, aiming to streamline development of genetic medicines.

FDA on paper texture | Image Credit: © Araki Illustrations.

IND Application Cleared for Phase II Trial of Grifols’ Dry Eye Disease Drops

Christopher Cole
May 21st 2025
Article

Grifols received FDA clearance to begin a Phase II trial of GRF312, an immunoglobulin eye drop for dry eye disease, aiming to improve current treatments.